Paradigm has responded to the US SEC, arguing that any MEV-related regulatory intervention would risk “disrupting a still-maturing but self-correcting market structure.” ...

Breakthrough research could make any IV drug able to be taken orally for a range of hard-to-treat cancers and other diseases, and redefine how medicines are designed, evaluated and delivered.

Internet users are frequently intrigued by the enigmatic codes, acronyms, and terms that abound in the digital realm. XAI770K ...

Titans Space's behemoth reusable spaceplanes represent a paradigm shift in human spaceflight, enabling large-scale, frequent, affordable, and safe missions. Marcus Beaufort, Director of Communications ...

Highly Credentialed Tech Executive to Drive the Launch of CyberAI Sentinel 2.0 Cybersecurity Initiatives MIAMI and NEW YORK ...

A distinguished economist and public affairs scholar, Friedman will lead a new school dedicated to advancing research and ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...

A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs into oral ...

HONG KONG, April 21, 2025 (GLOBE NEWSWIRE) -- On April 22, 2025, Luffa brought its North America Campus Tour to a successful ...

Analysts react to executive changes by its new CEO that include promotion of Sachin Katti to CTO and AI chief.

In addition, enterprises are beginning to experiment with agentic AI. Agentic AI is where individual AI-powered agents ...

The global digital telepathology market is undergoing a transformative evolution and is projected to reach approximately USD 934.8 million by 2025, expanding at a remarkable compound annual growth ...